BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T070000
DTEND;TZID=America/New_York:20201104T090000
DTSTAMP:20201101T235235Z
CREATED:20201022T224522Z
LAST-MODIFIED:20201101T235235Z
UID:47772-1604473200-1604480400@globalbiodefense.com
SUMMARY:Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting
DESCRIPTION:The GHSA Consortium for the GHSA Task Force on Advocacy & Communications will host a Side Meeting at the 6th Global Health Security Agenda Ministerial Meeting on 4 November 2020. \nThis side event will highlight promising practices for meaningfully expanding partnerships across human\, animal\, agriculture\, and environmental sectors to improve health outcomes and local\, national\, and global health security. \nHighlighted topics include: \n\nIdentifying good\, better\, and best practices\nWildlife and environment: Connections to health security\nFostering multisectoral coordination in countries to effectively contain antimicrobial resistance\nCommunicating across sectors: Early warning systems and preparedness\nSustaining engagement with environment sector partners: Systems\, processes\, capacity and resources\n\nThe event will take place 0700-0900 EST (New York) and 1900-2100 local (Thailand). \nPlease register via the GHSA Ministerial website. Once registered\, the event will be broadcast from: https://www.ghsamm2020.com/streams/245 \nAbout GHSA \nThe Global Health Security Agenda (GHSA) 2024 Framework emphasizes the importance of engaging all relevant sectors to achieve sustainable and measurable results toward common targets for global health security. Changing conditions at local and global scales – related to deforestation and habitat loss\, wildlife trade\, and changing food systems and agricultural intensification with inadequate biosecurity – are shaping novel and increased interactions between species that facilitate opportunities for the spillover of disease. \nThe consequences are striking: more than 70% of emerging zoonotic diseases have origins in wildlife\, and climate-sensitive vector-borne diseases are appearing in new regions\, together causing extensive health and economic impact. The same drivers\, combined with the misuse and overuse of antibiotics\, have accelerated the emergence of antimicrobial resistance (AMR) among interconnected microbiomes in humans\, animals\, and the environment\, which can be spread across borders through trade\, travel\, and other movement of people and animals. Understanding the links between the environment and health risks and outcomes is critical to enhancing surveillance and detection\, develop early warning systems\, and target multisectoral risk reduction strategies to address known and novel threats. \n 
URL:https://globalbiodefense.com/event/side-meeting-at-the-6th-global-health-security-agenda-ministerial-meeting/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/ghsa-side-event-global-health-security-agenda.jpg
LOCATION:https://www.ghsamm2020.com/streams/245
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201104T121500
DTEND;TZID=America/New_York:20201104T131500
DTSTAMP:20201103T012824Z
CREATED:20201003T002424Z
LAST-MODIFIED:20201103T012824Z
UID:47785-1604492100-1604495700@globalbiodefense.com
SUMMARY:FDA Virtual Town Hall Series - COVID-19 Test Development and Validation
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers 4 Nov 2020 from 12:15 PM – 1:15 PM Eastern. \nThe FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases\, including the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is committed to providing timely guidance to support response efforts to this pandemic. \nThe immediately in effect guidance “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” includes policies specific to this public health emergency. This guidance was issued on February 29\, 2020 and subsequently updated on March 16\, 2020\, May 4\, 2020\, and May 11\, 2020. \nThe FDA will also hold virtual Town Halls for test developers to help answer questions on: \n\nNovember 18\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 2\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 9\, 2020 from 12:15 pm – 1:15 pm Eastern Time\nDecember 16\, 2020 from 12:15 pm – 1:15 pm Eastern Time\n\nLearn more
URL:https://globalbiodefense.com/event/fda-virtual-town-hall-series-covid-19-test-development-and-validation/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T120000
DTEND;TZID=America/New_York:20201105T130000
DTSTAMP:20201101T235722Z
CREATED:20201023T054551Z
LAST-MODIFIED:20201101T235722Z
UID:47610-1604577600-1604581200@globalbiodefense.com
SUMMARY:USAID: Conflict Assessment Framework
DESCRIPTION:Join HDIAC Thursday\, November 5 for a webinar presentation titled “USAID: Conflict Assessment Framework.”  \nIn order to best understand the environments where they work\, the United States Agency for International Development (USAID) uses a diagnostic tool called the Conflict Assessment Framework to analyze national and sub-national conflict. A conflict assessment is a systematic process used to analyze and prioritize the dynamics of peace\, conflict\, stability\, and instability in a given country context. The assessment consists of two stages: diagnosis and response. During the diagnosis phase\, the assessment team gathers information about the country’s internal conflict dynamics. The team then uses its findings to identify likely future scenarios that could alter a country’s risk of violent conflict. During the response stage\, the assessment team draws on its rich diagnostic analysis to formulate actionable responses. Conducting a field-based conflict assessment is challenging. It involves applying a set of rigorous analytical tasks in a dynamic process\, which must be sensitive to issues from policy positions\, organizational interests\, interpersonal and intercultural dynamics\, language\, and logistical constraints. This webinar will provide an overview of the assessment process and methods\, as well as provide illustrative examples from previously conducted field assessments.  \nPlease register in advance for the webinar.
URL:https://globalbiodefense.com/event/usaid-conflict-assessment-framework/
CATEGORIES:Webinar-Webcast
LOCATION:https://www.anymeeting.com/PIID=EF55D884864F3F
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201105T120000
DTEND;TZID=America/New_York:20201105T140000
DTSTAMP:20200927T193658Z
CREATED:20200927T193658Z
LAST-MODIFIED:20200927T193658Z
UID:47219-1604577600-1604584800@globalbiodefense.com
SUMMARY:Changes in Pathogen Exposure Pathways under Non-Stationary Conditions and Their Implications for Wildlife and Human Exposure on DoD Lands
DESCRIPTION:A webinar on “Changes in Pathogen Exposure Pathways under Non-Stationary Conditions and Their Implications for Wildlife and Human Exposure on Department of Defense Lands” will be presented on Nov. 5\, 2020. \nHosted by the Strategic Environmental Research and Development Program (SERDP) and Environmental Security Technology Certification Program (ESTCP)\, this seminar will be presented by Dr. Sara Olson from the Wildlife Conservation Society. \nA fungal disease called white-nose syndrome (WNS)\, originally identified in 2006 in New York state\, has killed millions of hibernating bats in North America. In advance of its spread across western North America\, this research effort involved the collection of empirical data on bat hibernation physiology to better inform our understanding of western bat WNS risk factors and priorities for possible mitigations. As part of this work\, we hypothesized that the differential mortality due to WNS observed among hibernating species was related to species-level bioenergetic traits and environmental factors. Our hypothesis was tested using empirical data and bioenergetic models. In advance of WNS arrival\, our team collected basic morphometric trait data on 3\,073 bats representing 14 species across 14 sites in Alberta\, British Columbia\, Colorado\, Montana\, Northwest Territories\, Nevada\, Oklahoma\, Oregon\, Texas and Utah. Respirometry and body composition data were collected for a subset of 580 and 464 bats\, respectively\, for analysis of 12 species. Microclimate measurements were also collected within hibernacula. The data collected as part of this effort are the first to establish valuable pre-WNS reference points for the hibernation physiology of these western bat species. The data\, analyses and modeling tools presented during this webinar will help inform DoD and other land managers who are responsible for bat management and mitigation activities by identifying specific WNS risk factors as well as susceptible and more resilient western species and populations. \nDr. Sarah Olson is the Associate Director of Epidemiology for the Wildlife Conservation Society (WCS) Health Program. Although the program is based out of the Bronx Zoo in New York\, Dr. Olsen is physically based out of Bozeman\, Montana. Her ongoing research efforts focus on assessing the risk of white-nose disease syndrome to North American hibernating bats\, tracking human health threats associated with wildlife trade in Asia\, establishing national wildlife health surveillance platforms\, and researching the disease ecology of filoviruses in Central African fruit-bats. In addition to leading scientific studies\, Dr. Olson provides research support to field veterinarians and conservation staff around the world on wildlife health threats and zoonotic diseases with a focus on promoting the understanding of conservation impact of front-line wildlife diseases\, building One Health capacity\, and translating science into effective and lasting interventions. She received bachelor’s degrees in microbiology and German from Montana State University\, and a joint doctoral degree in population health and environment from the University of Wisconsin in Madison. \nLearn more here.
URL:https://globalbiodefense.com/event/changes-in-pathogen-exposure-pathways-under-non-stationary-conditions-and-their-implications-for-wildlife-and-human-exposure-on-dod-lands/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201109
DTEND;VALUE=DATE:20201111
DTSTAMP:20201108T212120Z
CREATED:20201101T211658Z
LAST-MODIFIED:20201108T212120Z
UID:47853-1604880000-1605052799@globalbiodefense.com
SUMMARY:Aberdeen Proving Ground Virtual Career Fair
DESCRIPTION:Organizations across Aberdeen Proving Ground will accept resumes during the installation’s first virtual career fair November 9 and 10\, 2020. \nThe virtual hiring event\, hosted by the U.S. Army Communications-Electronics Command\, will provide opportunities for applicants to submit their resumes and other information through an online\, mobile recruiting application. \n“We are excited for our first ever virtual job fair for the APG community\,” said CECOM Human Resources Specialist Steve Faulkner. “COVID-19 has forced us all into being more innovative in our approach in human resources\, particularly in recruiting.” \nIn an effort to practice social distancing\, about half a dozen APG organizations and subordinate commands will use the virtual event to recruit candidates for a variety of career fields in multiple locations. For career opportunities in information technology\, law enforcement\, engineering\, financial management\, logistics\, communications\, just to name a few\, applicants will apply for positions from the safety of their personal computers and mobile devices. \nAPG – Career Fair\nAPG is relying on its social media channels to promote hiring opportunities\, and to engage potential candidates. Job seekers are encouraged to ask questions and share the event information with friends\, to ensure high visibility and maximum participation. \n“To meet the mission\, hiring organizations must continue to hire the best qualified employees\,” Faulkner said. “We have opportunities at APG; Tobyhanna\, Pennsylvania; Fort Detrick\, Maryland; Fort Huachuca\, Arizona; Fort Belvoir\, Virginia\, and many more locations.” \nSome of the participating organizations include CECOM\, the Army 20th CBRNE Command\, APG Garrison\, Army Futures Command organizations\, Army Medical Research Institute of Chemical Defense (USAMRICD)\, Army Program Executive Office – Command\, Control and Communications Tactical and many more. \nThe APG workforce has more than 21\,000 military\, civilian and contractor employees responsible for numerous technical achievements across a broad spectrum of military capabilities. If a Soldier uses a piece of technology for protection\, intelligence\, shooting\, movement or to communicate\, chances are it was developed\, tested and fielded by an APG organization. \nThe APG Virtual Career Fair event page on Facebook includes information on hiring organizations and how to submit resumes. Learn more: https://www.facebook.com/events/354326535799511
URL:https://globalbiodefense.com/event/aberdeen-proving-ground-virtual-career-fair/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/11/apg-usamricd-virtual-career-fair.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201112T183000
DTEND;TZID=America/New_York:20201112T200000
DTSTAMP:20201109T150749Z
CREATED:20201023T041149Z
LAST-MODIFIED:20201109T150749Z
UID:47599-1605205800-1605211200@globalbiodefense.com
SUMMARY:GMU Schar School Master’s and Certificate Virtual Open House
DESCRIPTION:You’re invited to attend a virtual open house to learn more about the Schar School of Policy and Government and our academic programs. The online session will provide an overview of our master’s degree programs and graduate certificate programs\, student services\, and admissions requirements. \nFormer Deputy Director of the FBI Andrew McCabe\, now a Schar School Distinguished Visiting Professor\, will also greet prospective students and share his security experience. \nPlease visit the GMU Schar School website here for more information: Master’s and Certificate Virtual Open House
URL:https://globalbiodefense.com/event/gmu-schar-school-masters-and-certificate-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/gmu-open-house-virtual-event-andrew-mccabe.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201117T120000
DTEND;TZID=America/New_York:20201117T133000
DTSTAMP:20201113T195436Z
CREATED:20201023T051656Z
LAST-MODIFIED:20201113T195436Z
UID:47602-1605614400-1605619800@globalbiodefense.com
SUMMARY:The Resurgent Chemical Weapons Threat: Current Challenges to the Chemical Weapons Convention
DESCRIPTION:The chemical weapons nonproliferation regime is at a crossroads. Chemical weapons have made a comeback with deadly nerve agents being used by Russia\, Syria\, and North Korea against perceived “enemies of the state.” Join a distinguished panel of international experts in a discussion about how to restore the taboo against the use of chemical weapons and how the organization for the Prohibition of Chemical Weapons (OPCW) can prevent the further misuse of chemistry. \nPANELISTS: \nDr. Stefano Costanzi is an Associate Professor of Chemistry at American University in Washington DC. \nDr. Malcolm Dando is a Leverhulme Trust Emeritus Fellow in the Department of Peace Studies at the University of Bradford in the UK. \nDr. Jean Pascal Zanders is an independent researcher/consultant on disarmament and security based in France. \nThe event will be moderated by Dr. Gregory D. Koblentz\, Associate Professor and Director of the Biodefense Graduate Program at the Schar School of Policy and Government at George Mason University. \nPlease visit the Schar School website for more information: The Resurgent Chemical Weapons Threat: Current Challenges to the Chemical Weapon Convention.
URL:https://globalbiodefense.com/event/the-resurgent-chemical-weapons-threat-current-challenges-to-the-chemical-weapon-convention/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/schar-school-resurgent-chemical-weapons-threat-cwc.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201117T190000
DTEND;TZID=Europe/London:20201117T203000
DTSTAMP:20201106T161357Z
CREATED:20201106T161308Z
LAST-MODIFIED:20201106T161357Z
UID:47845-1605639600-1605645000@globalbiodefense.com
SUMMARY:Toxic: A History of Nerve Agents
DESCRIPTION:The Royal Institution will host a live stream talk led by Dan Kaszeta on “A History of Nerve Agents” on Tuesday 17 November. \nNerve agents are the world’s deadliest means of chemical warfare. Kaszeta uncovers the development and propogation of these deadly compounds\, from their Nazi invention to their recent use by assassins in Salisbury\, England. \nDan Kaszeta has decades of experience in protecting against chemical and biological weapons\, and has held positions in the US Army\, the White House Military Office\, the US Secret Service and private industry. \nThe event is free but donations are encouraged. Learn more.
URL:https://globalbiodefense.com/event/toxic-a-history-of-nerve-agents/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201130T033000
DTEND;TZID=America/New_York:20201130T070000
DTSTAMP:20201101T174433Z
CREATED:20201101T174433Z
LAST-MODIFIED:20201101T174433Z
UID:47768-1606707000-1606719600@globalbiodefense.com
SUMMARY:Biological Weapons Convention: Orientation Workshop
DESCRIPTION:In preparation for the Biological Weapons Convention (BWC) 2020 Meeting of Experts in December 2020\, UNIDIR is hosting a brief BWC Orientation course for national delegates. The event will provide a basic introduction to the BWC and some of the key issues facing the Convention. It will also serve as opportunity for delegates to informally ask experts in the field any questions they may have related to the BWC. \nThe event will comprise of several short segments covering topics including international cooperation\, science and technology\, and transparency and compliance. UNIDIR will moderate the event. Confirmed speakers include: \n\nRichard Lennane\nZalini Binti Yunus\nYasemin Balci.\n\nLearn more: http://bit.ly/unidir-bwc-orientation
URL:https://globalbiodefense.com/event/biological-weapons-convention-orientation-workshop/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201201
DTEND;VALUE=DATE:20201203
DTSTAMP:20201127T195218Z
CREATED:20201127T195203Z
LAST-MODIFIED:20201127T195218Z
UID:48069-1606780800-1606953599@globalbiodefense.com
SUMMARY:Security of America’s Medical Product Supply Chain - Public Workshop
DESCRIPTION:The National Academies’ Committee on Security of America’s Medical Product Supply Chain will host its second meeting and a public workshop from December 1-3\, 2020. \nThe public workshop will be held on December 1 (12:00pm to 3:30pm) and December 2 (11:30am to 3:30pm). \nObjectives for the public workshop include the following: \n\nConsider on-the-ground perspectives from end users of the medical supply chain (e.g.\, patients\, clinicians\, health systems) when it comes to:\n\nwhat makes a medical product critical/essential\noutcome measures that matter to end users\napproaches to mitigate the impact of failures in the medical supply chain\n\n\nExamine current lists of “critical/essential” medical products with attention to how these lists were formulated and how they are used to inform decisions;\nDiscuss key considerations for the formulation of a unified list of critical medical products;\nConsider tactical approaches for improving supply chain resiliency.\n\nBackground\nIn response to the CARES Act\, the National Academies of Sciences\, Engineering\, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain. \nThe committee will: \n1) assess and evaluate the dependence of the United States\, including the private commercial sector\, States\, and the Federal Government\, on critical drugs and devices that are sourced or manufactured outside of the United States\, which may include an analysis of: \n\nthe supply chain of critical drugs and devices of greatest priority to providing health care;\nany potential public health security or national security risks associated with reliance on critical drugs and devices sourced or manufactured outside of the United States\, which may include responses to previous or existing shortages or public health emergencies\, such as infectious disease outbreaks\, bioterror attacks\, and other public health threats;\nany existing supply chain information gaps\, as applicable; and\npotential economic impact and other considerations associated with increased domestic manufacturing; and\n\n2) provide recommendations to improve the resiliency of the supply chain for critical drugs and devices and to address any supply vulnerabilities or potential disruptions of such products that would significantly affect or pose a threat to public health security or national security\, as appropriate\, which may include strategies to: \n\npromote supply chain redundancy and contingency planning;\nencourage domestic manufacturing\, including consideration of economic impacts\, if any;\nimprove supply chain information gaps;\nimprove planning considerations for medical product supply chain capacity during public health emergencies; and\npromote the accessibility of such drugs and devices.
URL:https://globalbiodefense.com/event/security-of-americas-medical-product-supply-chain-public-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T170000
DTEND;TZID=America/New_York:20201201T180000
DTSTAMP:20201127T194745Z
CREATED:20201127T194745Z
LAST-MODIFIED:20201127T194745Z
UID:48067-1606842000-1606845600@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH - Meeting 8
DESCRIPTION:The Eighth Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health (NIH) will be held virtually on December 1\, 2020. \nWhat is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will conduct a study of the economic and healthcare benefits of the SBIR and STTR programs at NIH and the effectiveness of the enabling strategies NIH has employed to enhance the programs. \nMeeting will be held via Zoom. This meeting will be open in its entirety. \nPlease write to step@nas.edu to attend. \nBackground\nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih-meeting-8/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T110000
DTEND;TZID=America/New_York:20201203T143000
DTSTAMP:20201127T210413Z
CREATED:20201127T210413Z
LAST-MODIFIED:20201127T210413Z
UID:48071-1606993200-1607005800@globalbiodefense.com
SUMMARY:Lessons Learned in Health Professions Education from the COVID-19 Pandemic
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and conduct a 1-day public workshop on Dec. 3\, 2020 to explore lessons learned in grand challenges facing health professions education (HPE) stemming from the COVID-19 pandemic and how those positive and negative experiences might inform development of sustainable improvements in the value\, effectiveness\, and impact of HPE. The planning committee will bring together educators\, students\, administrators\, and health professionals to share ideas\, stories\, and data in an effort to discuss the future of HPE by learning from past experiences. Invited presentations and discussions will involve global audiences in topics such as: \n\nExamples and evaluation of online education;\nInnovations in interprofessional education and learning opportunities within the social determinants of health and mental health;\nImpacts on pre-clinical and clinical education;\nRegulatory and accreditation changes affecting HPE; and\nStress and workload on students and faculty.\n\nRegister here.
URL:https://globalbiodefense.com/event/lessons-learned-in-health-professions-education-from-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201210
DTSTAMP:20201127T212644Z
CREATED:20201127T212644Z
LAST-MODIFIED:20201127T212644Z
UID:48073-1607299200-1607558399@globalbiodefense.com
SUMMARY:DoD Materials Science and Engineering in a Post-Pandemic World: A Workshop
DESCRIPTION:How has COVID-19 affected Department of Defense materials and manufacturing capabilities\, and what does this mean for future workforce needs? The National Academies invites you to explore Materials Science and Engineering in a Post-Pandemic World as part of a three-day virtual public workshop December 7-9\, 2020. \nWorkshop topics will include 1) how COVID-19 is impacting and is expected to impact DOD materials and manufacturing capabilities; 2) how the current materials and manufacturing workforce is affected; 3) efforts being considered to address future DOD materials and manufacturing needs; and 4) the future of the DOD workforce pipeline. \nLearn more and register: https://bit.ly/dod-post-pandemic-mfc \n 
URL:https://globalbiodefense.com/event/dod-materials-science-and-engineering-in-a-post-pandemic-world-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201210T190000
DTEND;TZID=America/New_York:20201210T200000
DTSTAMP:20201127T215208Z
CREATED:20201127T215208Z
LAST-MODIFIED:20201127T215208Z
UID:48075-1607626800-1607630400@globalbiodefense.com
SUMMARY:Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic
DESCRIPTION:A webcast talk on “Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic” will be held December 10\, 2020 as Part 4 in the webinar series\, “Moving Forward in the Midst of a Pandemic: International Lessons for Math Teachers” Hosted by the U.S. National Commission of Mathematics Instruction – National Academies of Sciences\, Engineering\, and Medicine \nAbout the speaker:\nPatricio Felmer is a Mathematical Engineer from the University of Chile and holds a Ph.D. in Mathematics from the University of Wisconsin-Madison.  He has been Director of the Department of Mathematical Engineering (1999-2001)\, Member of the Fondecyt Higher Science Council (2002-2005)\, and is a member of the Chilean Academy of Sciences.  Dr. Felmer dedicated the first part of his academic life to mathematical research\, making numerous scientific contributions in the area of Hamiltonian systems\, partial differential equations and nonlinear analysis.  In the second part\, he has directed his interests to education\, dedicating his efforts to collaborate in the improvement of education with a country vision.  Together with collaborators\, he founded the ARPA Initiative\, a teacher professional development program\, whose purpose is to incorporate Problem Solving in Chilean classrooms\, with the goal of transforming classroom relationships.  The proposal seeks to move a classroom conducted by the teacher\, with passive students\, to one where students actively learn and the teacher orchestrate their work\, proposing stimulating activities\, and promoting autonomy and collaboration.
URL:https://globalbiodefense.com/event/mathematics-problem-solving-and-professional-development-under-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201214
DTEND;VALUE=DATE:20201218
DTSTAMP:20200927T230726Z
CREATED:20200927T230726Z
LAST-MODIFIED:20200927T230726Z
UID:47223-1607904000-1608249599@globalbiodefense.com
SUMMARY:Brookhaven Laboratory Workshop for Industry Researchers
DESCRIPTION:Do you have an R&D challenge that you can’t solve with traditional commercial techniques? This specialized virtual workshop will offer access to unique x-ray\, electron and optical techniques\, which are designed for understanding materials in unprecedented ways. \nBrookhaven National Laboratory will host a virtual workshop on December 14-17\, 2020 for industry researchers to showcase the capabilities and expertise available at U.S. Department of Energy (DOE) Office of Science User Facilities located at Brookhaven Lab. \nThe workshop is designed to benefit both researchers who have previously used Brookhaven facilities for their work and those who are interested in learning about accessing them for the first time. \nThe workshop will inform researchers from industry about the leading-edge capabilities and expertise at Brookhaven facilities\, and provide details about the mechanisms for accessing them. The workshop will also more broadly introduce participants to DOE programs designed to support industry research. \nThe workshop agenda will feature presentations from industry users of Brookhaven Lab facilities\, question-and-answer sessions\, and opportunities to directly hear from Department of Energy program managers for your questions. \nHighlighted presentations include: \n\nBio and pharmaceuticals\nNanofabrication; Materials synthesis and characterization\nInnovative Chemistry through Advanced Microscopy Techniques\, Ke‐Bin Low\, BASF\nBio‐inspired invisible glass: from nature to commercialization\, Calvin Cheng\, Edgehog\nOverview of capabilities of NSLS‐II and CFN\, John Hill\, BNL\nX‐ray diffraction/scattering\nElectron microscopy\nHard and soft x‐ray spectroscopy\nAdvanced UV and x‐ray probes\nImaging and microscopy\nAdvanced optical spectroscopy and microscopy\nLessons learned as industry users of BNL facilities ‐‐ panel discussion\nDOE SBIR/STTR Program\, Manny Oliver\, SBIR/STTR Program Office\, DOE\nDOE TIR Program\, Eli Levine\, Advanced Manufacturing Office\, DOE\nDOE TCF Program\, Zack Baize\, Office of Technology Transitions\, DOE\nStrategic Partnership Program\, Ivar Strand\, BNL\nHelp desk and other DOE user facilities Q&A\nHow to become an industrial user and access facilities – Jun Wang (EPS)\nHow to write a good nonproprietary industrial proposal – Lisa Miller (NSLS‐II)\, Priscilla\nAntunez (CFN)\n\nThe workshop will provide a unique “facilities open house” format\, where attendees will spend time remotely in the labs observing Brookhaven’s capabilities in action and engaging in technical discussions with Brookhaven experts. The workshop will also provide an opportunity for attendees to remotely measure their own samples\, collecting meaningful data to take home that day. \nLearn more
URL:https://globalbiodefense.com/event/brookhaven-laboratory-workshop-for-industry-researchers/
LOCATION:Brookhaven Lab – Berkner Hall\, Lewis Road\, Upton\, 11973\, United States
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/brookhaven-national-lab-doe-science-user-facilities-industry-researchers-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201215T120000
DTEND;TZID=America/New_York:20201216T170000
DTSTAMP:20201127T221649Z
CREATED:20201127T221649Z
LAST-MODIFIED:20201127T221649Z
UID:48078-1608033600-1608138000@globalbiodefense.com
SUMMARY:Ethical\, Legal\, and Regulatory Issues Associated with Neural Chimeras and Organoids
DESCRIPTION:The fourth full meeting of the Committee on Ethical\, Legal\, and Regulatory Issues Associated with Neural Chimeras and Organoids will be held online December 15-16\, 2020. \nSome sessions are open to the public and some sessions are closed. \nThis ad hoc committee of the National Academies of Sciences\, Engineering\, and Medicine will examine the scientific\, ethical and regulatory issues associated with neural chimeras and neural organoid research. \nThe committee will review the status of research\, consider the benefits and risks of such research\, discuss associated ethical issues\, and consider what oversight mechanisms might be appropriate in this area. \nThe committee will consider questions such as: \n\nHow would researchers define or identify enhanced or human awareness in a chimeric animal?\nDo research animals with enhanced capabilities require different treatment compared to typical animal models? What are appropriate disposal mechanisms for such models?\nWhat types of brain tissue are appropriate for use as neural organoids?\nHow large or complex would the ex vivo brain organoids need to be to attain enhanced or human awareness?\nWhat kind of “humanized” brain\, in size and structures\, would be acceptable in a research animal?\nShould patients give explicit consent for their cells to be used to create neural organoids?\nWhat regulatory mechanisms relating to organoid and chimeric animal research are currently in place? Are there gaps in the current regulatory framework?\nWhat regulatory mechanisms exist for similar research?\nWhat further regulatory mechanisms might be appropriate?\n\nLearn more: https://bit.ly/neuralchimerasorganoids \n 
URL:https://globalbiodefense.com/event/ethical-legal-and-regulatory-issues-associated-with-neural-chimeras-and-organoids/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210112T160000
DTEND;TZID=America/New_York:20210112T173000
DTSTAMP:20210225T155956Z
CREATED:20201225T155643Z
LAST-MODIFIED:20210225T155956Z
UID:48627-1610467200-1610472600@globalbiodefense.com
SUMMARY:COVID-19 and Influenza & 1918 Influenza and COVID-19: A Tale of Two Pandemics
DESCRIPTION:A virtual presentation on “COVID-19 and Influenza & 1918 Influenza and COVID-19: A Tale of Two Pandemics” will be held on Jan 12\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nThe speakers for this virtual seminar are: \n\nAnthony Fauci\, MD (NIAID)\nJeffrey Taubenberger\, MD\, PhD (NIAID)\n\nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/covid-19-and-influenza-1918-influenza-and-covid-19-a-tale-of-two-pandemics/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41281
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210115T120000
DTEND;TZID=America/New_York:20210115T130000
DTSTAMP:20201230T161621Z
CREATED:20201230T161621Z
LAST-MODIFIED:20201230T161621Z
UID:48214-1610712000-1610715600@globalbiodefense.com
SUMMARY:The Continued Threat of Infectious Diseases to the U.S. Military
DESCRIPTION:Join the Homeland Defense & Security Information Analysis Center (HDIAC) for a webinar presentation on “The Continued Threat of Infectious Diseases to the U.S. Military” on Friday\, January 15\, from 1200 to 1300 EST. \nDuring deployment\, servicemembers are often at risk from infectious diseases which have the potential to impede the individual and the unit mission and cause significant morbidity and mortality. Diseases such as malaria\, dengue\, diarrheal diseases\, and many others threaten the force and require medical countermeasures to eliminate or mitigate the risk. \nDr. Stephen Thomas will explore the historical beginnings of global infectious disease threats\, review the epidemiology\, clinical presentation\, and current status of therapeutic and preventive measures for common threats. Additionally\, U.S. military contributions to countermeasure development will be discussed. \nABOUT THE SPEAKER \nDr. Stephen Thomas\, (Colonel\, US Army (Retired))\, has nearly 30 years of experience in infectious disease research. He is currently the Chief of the Division of Infectious Disease at SUNY Upstate Medical University\, a professor in both the Department of Microbiology and Immunology and the Department of Medicine\, and is an Infectious Diseases Consultant for the Syracuse Veterans Army Medical Center. Prior to his work in Syracuse\, Dr. (COL) Thomas was the Deputy Commander\, Walter Reed Army Institute of Research (WRAIR) and WRAIR Chief of Virology\, an Infectious Disease Consultant to the Surgeon General in US Army Medical Command\, and the Director of Dengue Vaccine Development for the Armed Forces Research Institute of Medical Sciences in Bangkok. Dr. Thomas has authored numerous publications\, most recently focusing on Zika and Dengue. He is a member of the Infectious Disease Society of America\, the American Society of Tropical Medicine and Hygiene\, and the American College of Physicians. He received his BA from Brown University and his MD from Albany Medical College. \nPlease register in advance for the webinar at: https://www.anymeeting.com/PIID=EF59DA85844938
URL:https://globalbiodefense.com/event/the-continued-threat-of-infectious-diseases-to-the-u-s-military/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210119T160000
DTEND;TZID=America/New_York:20210119T180000
DTSTAMP:20210225T162543Z
CREATED:20210225T162543Z
LAST-MODIFIED:20210225T162543Z
UID:48635-1611072000-1611079200@globalbiodefense.com
SUMMARY:Immunological and Genetic Features of COVID-19 and Rapid Vaccine Development
DESCRIPTION:A virtual presentation on “Immunological and Genetic Features of COVID-19 and Rapid Vaccine Development” will be held on January 19\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers: \nLuigi Daniele Notarangelo\, M.D. is Senior Investigator\, Immune Deficiency Genetics Section\, NIAID/DIR. The main goal of the Immune Deficiency Genetics Section (IDGS) is to characterize the molecular and cellular mechanisms underlying primary immune deficiencies\, and combined immunodeficiencies (CID) in particular\, with the ultimate objective of improving diagnosis and treatment of these conditions. Luigi D. Notarangelo received his M.D. from the University of Pavia\, Italy. After completing training in pediatrics\, subspecialty training in allergy/immunology\, and human genetics at the University of Pavia and a postdoctoral internship with David Nelson\, M.D.\, at the Metabolism Branch\, National Cancer Institute\, he was appointed associate professor and subsequently full professor of pediatrics at the University of Brescia\, Italy\, where he chaired the department of pediatrics between 2000 and 2006. In November 2006\, he joined the division of immunology at Boston Children’s Hospital\, Harvard Medical School\, as professor of pediatrics. In October 2016\, he joined the Laboratory of Host Defenses. Dr. Notarangelo is a leader in the study of the molecular and cellular mechanisms of human primary immune deficiencies and in the treatment of these disorders. He has served as president of the European Society for Immune Deficiencies and of the Clinical Immunology Society. He has received numerous national and international awards. \nBarney S. Graham\, M.D.\, Ph.D. is Senior Investigator\, Viral Pathogenesis Laboratory and Translational Science Core\, NIAID Vaccine Research Center (VRC). Dr. Graham serves as Deputy Director of the NIAID Vaccine Research Center and assists the Director in establishing and focusing the scientific direction for the VRC as a premier intramural research organization. As Chief of the Viral Pathogenesis Laboratory\, Dr. Graham also leads the development efforts for COVID-19 vaccines and universal influenza vaccines. In addition\, he supports VRC product development through strategic advice on vaccine design as well as pre-clinical and clinical evaluation. Dr. Graham is an immunologist\, virologist\, and clinical trials physician whose primary interests are viral pathogenesis\, immunity\, and vaccine development. His laboratory is focused on respiratory viral pathogens\, pandemic preparedness\, and emerging viral diseases. He applies structural biology\, protein engineering\, and other new technologies to create vaccines for unmet needs and emerging threats advancing the principles of precision vaccinology. He has been involved in the clinical evaluation of candidate vaccines for more than 30 years and has an ongoing interest in science education and expanding research opportunities for underrepresented minorities. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/immunological-and-genetic-features-of-covid-19-and-rapid-vaccine-development/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41282
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210203T140000
DTEND;TZID=America/New_York:20210203T150000
DTSTAMP:20210130T234651Z
CREATED:20210130T234547Z
LAST-MODIFIED:20210130T234651Z
UID:48420-1612360800-1612364400@globalbiodefense.com
SUMMARY:ZOHU Call - Zoonoses & One Health Updates
DESCRIPTION:Zoonoses & One Health Updates (ZOHU) Calls are one-hour monthly webinars that provide timely education on zoonotic and infectious diseases\, One Health\, antimicrobial resistance\, food safety\, vector-borne diseases\, recent outbreaks\, and related health threats at the animal-human-environment interface.\n\nThe following is the agenda for the February 3\, 2021 ZOHU Call:\n\nOne Health News from CDC\nCasey Barton Behravesh\, MS\, DVM\, DrPH\, DACVPM\nCaptain\, U.S. Public Health Service\nDirector\, One Health Office\nCenters for Disease Control and Prevention\ndlx9@cdc.gov \nNASA and NOAA Earth Observations for Health and Air Quality Application\nJohn Haynes\, MS\nProgram Manager\, Health and Air Quality Applications\nNational Aeronautics and Space Administration Earth Science Division\njhaynes@nasa.gov\nAND\nJuli M. Trtanj\, MES\nNOAA One Health and Integrated Climate Research Lead\nNational Oceanic and Atmospheric Administration Climate Program Office\njuli.trtanj@noaa.gov \nSurveillance for Harmful Algal Bloom Events and Associated Human and Animal Illnesses — One Health Harmful Algal Bloom System\, United States\, 2016–2018\nVirginia A. Roberts\, MSPH\nEpidemiologist\nWaterborne Disease Prevention Branch\nNational Center for Emerging and Zoonotic Infectious Diseases\nCenters for Disease Control and Prevention\nevl1@cdc.gov \nExploration of Decontamination Strategies for Odor Detection Canines\nJulia Patrone\, PhD\nSenior Scientist\nJohns Hopkins Applied Physics Laboratory\njulia.patrone@jhuapl.edu\nAND\nKaren Meidenbauer DVM\, MPH\nSenior Scientist/Veterinarian\nJohns Hopkins Applied Physics Laboratory\nkaren.meidenbauer@jhuapl.edu \nThe target audience for ZOHU Calls include: \n\nAcademics\nAdministrators\nAgriculture\nAnimal health officials\nAnimal industry\nEnvironmental health professionals\nEpidemiologists\nHealth educators and communicators\nHuman health professionals\nLaboratorians\nNon-governmental organizations\nProgram managers\nPublic health professionals\nStudents\nVeterinarians/vet technicians\nWildlife officials\n\n\nA captioned recording will be posted within 30 days after the call.
URL:https://globalbiodefense.com/event/zohu-call-zoonoses-one-health-updates/
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
LOCATION:https://cdc.zoomgov.com/j/1611576470?pwd=bUxSZGk3TCt5dGhCSkg5cko1dGk5Zz09
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210206
DTEND;VALUE=DATE:20210207
DTSTAMP:20200212T000700Z
CREATED:20200212T000357Z
LAST-MODIFIED:20200212T000700Z
UID:39317-1612569600-1612655999@globalbiodefense.com
SUMMARY:Application Deadline: Expanding Existing Research Grants\, CRADAs for Novel Coronavirus Response
DESCRIPTION:A Notice of Special Interest (NOSI) was issued on Feb. 6\, 2020 to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV) jointly by National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of General Medical Sciences (NIGMS). \nApplications will be accepted on a rolling basis from February 6\, 2020 through February 6\, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on February 6\, 2021. An application submitted in response to this NOSI that is received on February 6\, 2021 or later\, will be withdrawn. \nRead more about this opportunity in Funding News \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/application-deadline-expanding-existing-research-grants-cradas-for-novel-coronavirus-response/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210209T110000
DTEND;TZID=America/New_York:20210209T150000
DTSTAMP:20201127T192957Z
CREATED:20201127T192831Z
LAST-MODIFIED:20201127T192957Z
UID:48059-1612868400-1612882800@globalbiodefense.com
SUMMARY:Envisioning a Transformed Clinical Trials Enterprise for 2030 - Session 2
DESCRIPTION:The National Academies’ Forum on Drug Discovery\, Development\, and Translation will host a virtual public workshop on Feb 9\, 2021 as part of a web series forum of events to discuss critical policy for advancement of biopharmaceutical innovation nationally and globally. \nThis virtual public workshop will provide a venue for stakeholders to consider a transformed clinical trial enterprise for 2030. Workshop participants will consider lessons learned from progress and setbacks over the past 10 years\, since the previous workshop\, Envisioning a Transformed Clinical Trials Enterprise in the United States\, and\, looking forward\, discuss goals and key priorities for advancing a clinical trials enterprise that is more efficient\, effective\, person-centered\, inclusive\, and integrated into the health delivery system of 2030. \nThe event will consider achievable goals to enhance person-centeredness and inclusivity in the clinical trials enterprise; and discuss ways to improve public engagement and partnership. \nBackground\nClinical trials research has changed dramatically over the last decade. The biological\, physical\, and digital spheres are merging; clinical research and health care are at a critical juncture; new approaches enable the collection of data in real-world settings; and new modalities\, such as digital health technologies and artificial intelligence applications\, are changing possibilities for the conduct of clinical research. \nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will plan and conduct a virtual public workshop designed to consider a transformed clinical trial enterprise for 2030\, featuring invited presentations and discussions on: \n\nLessons learned from progress and setbacks over the past 10 years.\n\n\nHow an envisioned 2030 clinical trials enterprise might differ from the current system.\n\n\nKey priority challenges and opportunities when it comes to the 2030 clinical trials enterprise.\n\n\nThe following core themes in framing a 2030 agenda:\n\n\nDiversity and inclusion of clinical trial participants\nConvergence of clinical research and clinical practice\nClinical trial data sharing\nIncorporation of new technologies into drug research and development\nWorkforce and career development\nPublic engagement and partnership\nRegulatory Environment\nCultural and Financial Incentives\n\n\nPractical short- and long-term goals for improving the efficiency\, effectiveness\, person-centeredness\, inclusivity\, and integration with healthcare of the clinical trials enterprise.\n\nFor additional information on the workshop series\, please visit the project page.
URL:https://globalbiodefense.com/event/envisioning-a-transformed-clinical-trials-enterprise-for-2030-session-2/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://www.nationalacademies.org/event/02-09-2021/envisioning-a-transformed-clinical-trials-enterprise-for-2030-a-virtual-workshop-webinar-session-2
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210223
DTEND;VALUE=DATE:20210226
DTSTAMP:20201127T225153Z
CREATED:20201127T225153Z
LAST-MODIFIED:20201127T225153Z
UID:48080-1614038400-1614297599@globalbiodefense.com
SUMMARY:Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks
DESCRIPTION:A virtual meeting hosted by the National Academies on February 23-25\, 2021 will examine ways to systemize and integrate the One Health approach as part of outbreak prevention\, detection\, preparedness\, and response efforts. \nThe workshop will explore research opportunities\, multi-sectoral collaboration mechanisms\, community engagement strategies\, educational opportunities\, and policies that can effectively implement the core capacities and interventions of One Health principles to strengthen national health systems and enhance global health security. \nSession 1 will take place Tuesday\, 23 February 2021 from 10:00am – 1:00pm EST. The first day will focus on the past – what One Health has accomplished thusfar\, and taking a look at the current state of affairs around the world. The “response” facet of outbreak preparedness will be highlighted. \nSession 2 will take place Wednesday\, 24 February 2021 from 10:00 – 1:00pm EST. The second day will focus on the present – what critical changes need to be made right now to incorporate One Health into national and global health systems? The “surveillance and detection” facet of outbreak preparedness will be highlighted. \nSession 3 will take place Thursday\, 25 February 2021 from 10:00am – 1:00pm EST. The third and final day will focus on the future – what capacities do we need to build down the line to ensure global health security? What lessons have we learned that can help pinpoint priority actions for incorporating One Health into national healthcare systems? The “forecasting and predicting” facet of outbreak preparedness will be highlighted. The third day will also include breakout room discussions recapping topical throughlines from throughout the 3-day workshop. \nSpecifically\, the workshop will feature invited presentations and discussions on the following: \n\nStrategies to systematize One Health in national prevention\, detection\, preparedness\, and response efforts;\nA review of One Health programs integrated into national and global public health efforts to learn what programs are current in effect:\nIntegration of animal and human health surveillance systems for cross-reporting to better understand pathogens in animals before (or after) spill-over to humans;\nFeasibility of introducing and integrating One Health into existing coordination mechanisms\, and into national action plans based on the Joint External Evaluation;\nStrengthening the global health workforce with One Health capacities;\nPolicies that underscore the interconnectedness of animal\, human\, and environmental health;\nImplications of using a One Health approach to improve preparedness vs. a reactionary response that is required to create medical countermeasures after outbreak onset;\nPromising practices for engaging with communities and influencing behaviors that lower the risk of infectious disease infection through the One Health approach;\nThe tension between public health needs\, the private sector and data sharing within the One Health context in preparedness and response efforts; and\nPotential priority actions to unite organizations – public and private\, domestic and international – in efforts to overcome newly discovered hurdles based on lessons learned from the COVID-19 pandemic.\n\nLearn more: https://bit.ly/nasem-one-health
URL:https://globalbiodefense.com/event/systematizing-the-one-health-approach-in-preparedness-and-response-efforts-for-infectious-disease-outbreaks/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210224T130000
DTEND;TZID=America/New_York:20210224T140000
DTSTAMP:20210217T195453Z
CREATED:20210217T195453Z
LAST-MODIFIED:20210217T195453Z
UID:48474-1614171600-1614175200@globalbiodefense.com
SUMMARY:COVID-19 Response Updates and Resources from CDC and the Ad Council
DESCRIPTION:This webinar will give participants the opportunity to hear from the nation’s premier public health organization\, the CDC and a second leadership organization in the public service advertising and social marketing sector\, The Ad Council. Both will share information and resources to help inform your local COVID-19 response messaging. The webinar will include time for Q&A from the audience. \nJohn Auerbach\, President and CEO\, Trust for America’s Health (Moderator) \nAnne Schuchat\, Principal Deputy Director\, Office of the Director\, CDC \nCharysse Nunez\, Insights Lead\, COVID Campaign\, The Ad Council \nJudy Monroe\, President and CEO\, CDC Foundation (Q&A facilitator)
URL:https://globalbiodefense.com/event/covid-19-response-updates-and-resources-from-cdc-and-the-ad-council/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://trustforamericashealth.webex.com/mw3300/mywebex/default.do?nomenu=true&siteurl=trustforamericashealth&service=6&rnd=0.019950858468937516&main_url=https://trustforamericashealth.webex.com/ec3300/eventcenter/event/eventAction.do%3FtheAction%3Ddetail%26%26%26EMK%3D4832534b00000004fd235543fe6bef08a6aecb3a4969a43ac215f8ae05a81cb8f3d6c7b8a899c6c6%26siteurl%3Dtrustforamericashealth%26confViewID%3D184599983942570680%26encryptTicket%3DSDJTSwAAAAR8fYe4Pp0F9RzMNsCO_2IqHfONrIMV-htYi1Vc2K5nTw2%26
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210225T143000
DTEND;TZID=America/New_York:20210225T160000
DTSTAMP:20210224T192420Z
CREATED:20210124T192057Z
LAST-MODIFIED:20210224T192420Z
UID:48614-1614263400-1614268800@globalbiodefense.com
SUMMARY:Defend The Flock: How Avian Influenza Affects Us All
DESCRIPTION:The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) invites you to join poultry health experts for a webinar on Thursday\, February 25. As part of Bird Health Awareness Week\, several poultry experts from across the country will host a discussion about what avian influenza is\, how it impacts different segments of the poultry industry and the surrounding communities\, and how to prevent the disease from affecting our Nation’s flocks. \nFrom December 2014 through June 2015\, the U.S endured its largest animal health emergency to date\, with more than 200 commercial and backyard premises affected with highly pathogenic avian influenza (HPAI) across the country\, and leading to the death of over 50 million birds. Recently\, cases of HPAI were confirmed in Europe\, Asia and Africa\, and many poultry owners and producers are concerned and want to take steps to protect their flocks. \nThe “Defend The Flock: How Avian Influenza Affects Us All” webinar will take place on Thursday\, February 25 from 2:30-3:30 PM EST. Register for this FREE webinar today at http://bit.ly/BirdHealthWebinar.
URL:https://globalbiodefense.com/event/defend-the-flock-how-avian-influenza-affects-us-all/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/WN_4L-8gBAzRMiJ41EnnPJrhA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210301
DTEND;VALUE=DATE:20210302
DTSTAMP:20210225T153427Z
CREATED:20210125T152534Z
LAST-MODIFIED:20210225T153427Z
UID:48617-1614556800-1614643199@globalbiodefense.com
SUMMARY:Rare Disease Day at NIH 2021 - Virtual Conference
DESCRIPTION:Rare Disease Day at NIH will be held virtually on Monday\, March 1\, 2021\, from 10:30 a.m. to 5:30 p.m. EST. This year’s event will feature interactive panel discussions\, rare stories through TED-style talks and more. \nThe event is free and open to the public\, including patients\, patient advocates\, health care providers\, researchers\, trainees\, students\, industry representatives and government employees. \nEach year\, the slogan for NIH’s event has been “Patients & Researchers — Partners for Life.” This slogan aligns with NCATS’ philosophy that researchers must work closely with patients\, families\, caregivers and advocacy groups to maximize the chances for success in advancing rare diseases research. This philosophy has been put into practice in NCATS’ Toolkit for Patient-Focused Therapy Development\, Rare Diseases Clinical Research Network(link is external)\, Therapeutics for Rare and Neglected Diseases program\, Rare Diseases Registry Program (RaDaR) and Genetic and Rare Diseases Information Center\, among other efforts. \nAbout 7\,000 rare diseases affect humans\, of which only a few hundred have any treatment. Although each rare disease affects fewer than 200\,000 Americans\, in total\, these illnesses affect an estimated 30 million people in the United States. \nCredit: CDC\nSince rare diseases often are difficult to diagnose\, it can take years to obtain an accurate diagnosis. Even after a proper diagnosis\, treatment often is unavailable\, because only about 5 percent of rare diseases have a treatment approved by the FDA. \nAs a result\, rare diseases are devastating and costly for patients\, their families and the nation as a whole. Most rare diseases are serious or life-threatening\, chronic and progressive disorders that place substantial medical and financial burdens on patients and their families. \nThrough its work to improve the science of collaboration\, NCATS supports collaborative and innovative approaches to research on rare diseases. NCATS’ Office of Rare Diseases Research (ORDR) facilitates and coordinates NIH-wide activities involving research for a broad array of rare diseases. These efforts have the potential to speed development of treatments for multiple rare diseases and ultimately help more patients more quickly. Learn more about ORDR and NCATS’ rare disease research programs and access shareable resources to help raise awareness about rare diseases.
URL:https://globalbiodefense.com/event/rare-disease-day-at-nih-2021-virtual-conference/
CATEGORIES:Awareness Event,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/02/rare-disease-day-nih-scaled.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210302
DTEND;VALUE=DATE:20210306
DTSTAMP:20210225T232420Z
CREATED:20210225T232420Z
LAST-MODIFIED:20210225T232420Z
UID:48654-1614643200-1614988799@globalbiodefense.com
SUMMARY:Effectiveness of Non-Vaccine Influenza Control Measures
DESCRIPTION:The National Academies will host a first committee meeting on Effectiveness of Non-Vaccine Influenza Control Measures on March 2-5\, 2021 in virtual format. \nThe event supports the Health and Medicine Division’s Public Health Interventions and Countermeasures for Advancing Pandemic and Seasonal Influenza Preparedness and Response project. \nThe global response to COVID-19 has pushed the boundaries of preparedness for a respiratory virus. At the request of the Office of Global Affairs within the U.S. Department of Health and Human Services\, the National Academies has convened a committee to analyze how the response to COVID-19 and related events could inform efforts to strengthen future preparedness for and response to seasonal and pandemic influenza. This committee will review non-vaccine public health interventions and countermeasures that can be vital to mitigating the spread and impact of a respiratory virus both before and after vaccines are available. \n\n\nThese virtual events (March 2\, 4\, and 5) will feature speakers with expertise on therapeutics\, non-vaccine public health interventions\, as well as surveillance for influenza and COVID-19. \nPlease visit the Effectiveness of Non-Vaccine Influenza Control Measures webpage for more information. \n 
URL:https://globalbiodefense.com/event/effectiveness-of-non-vaccine-influenza-control-measures/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210302T160000
DTEND;TZID=America/New_York:20210302T180000
DTSTAMP:20210225T162756Z
CREATED:20210225T154652Z
LAST-MODIFIED:20210225T162756Z
UID:48622-1614700800-1614708000@globalbiodefense.com
SUMMARY:RNA Viruses: How They Do What They Do
DESCRIPTION:A virtual presentation on “RNA Viruses: How They Do What They Do” will be held on March 2\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speakers \nDr. Nihal Altan-Bonnet received her B.A. in biology and chemistry from Hunter College\, New York in 1992 and her Ph.D. in cell biology from The Rockefeller University in 1998. She then conducted postdoctoral research with Dr. Jennifer Lippincott-Schwartz at the National Institute of Child Health and Development at the NIH from 1999 to 2005 before receiving a faculty position in the department of biological sciences at Rutgers University. In 2013\, Dr. Altan-Bonnet returned to the NIH as an Earl Stadtman Investigator\, becoming head of the Laboratory of Host-Pathogen Dynamics at the NHLBI and was promoted to tenured Senior investigator in 2017. Dr. Altan-Bonnet has been recognized several times for her outstanding research\, receiving the Presidential Early Career Award in Science and Engineering (PECASE) in 2012\, being named the John J. Holland lecturer at the American Society of Virology in 2017\, and receiving the Norman Salzman Mentor Award in Virology in 2018. Dr. Altan-Bonnet was also named a Kavli Fellow and Scialog Fellow from 2013-2016. She is an Associate editor at the Molecular Biology of the Cell and is a member of the American Societies for Virology\, Microbiology\, and Cell Biology. \nKarla Kirkegaard\, Ph.D.\, is the Violetta L. Horton Research Professor of Genetics and former Chair of the Department of Microbiology and Immunology in the Stanford University School of Medicine. She received her Ph.D. in Biochemistry and Molecular Biology with James C. Wang at Harvard University\, and performed her postdoctoral work in the laboratory of David Baltimore at the Whitehead Institute. As an Assistant and Associate Professor at the University of Colorado in Boulder\, she received numerous awards\, including a fellowship from the David and Lucile Packard Foundation\, an American Cancer Society Young Investigator Award\, a Searle Scholar Award\, and sponsorship by the Howard Hughes Medical Institute. Dr. Kirkegaard combined her interests in biochemistry\, cell biology\, and genetics in the study of RNA virology\, using poliovirus and other positive-strand RNA viruses to understand the cell biology of viral infections and the genetics of viral variability. Since her move to Stanford University School of Medicine in 1996\, her interests have focused increasingly on the impact of basic science discoveries on the transmission of viruses in infected hosts. Kirkegaard’s honors include an Ellison Foundation Senior Scholar Award in Global Infectious Disease and\, in 2006\, the NIH Director’s Pioneer Award\, for her approach to guide the selection of antiviral targets with the goal of suppressing the drug-resistant RNA genomes that will inevitably be formed due to the high error rates of RNA replication. She has been recently elected as a Member of the National Academies of Arts and Sciences and a Fellow of the American Association for the Advancement of Science. Her work continues to focus on the mechanisms of diversity and propagation of viruses and suppression of this diversity and spread. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/rna-viruses-how-they-do-what-they-do/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41288
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210302T170000
DTEND;TZID=America/Los_Angeles:20210302T190000
DTSTAMP:20210223T213836Z
CREATED:20210223T211535Z
LAST-MODIFIED:20210223T213836Z
UID:48583-1614704400-1614711600@globalbiodefense.com
SUMMARY:COVID Seminar Series - Hindsight is 2020
DESCRIPTION:The Pacific Northwest National Laboratory will host a COVID Seminar Series event on March 2: “Hindsight is 2020”. The Community Science and Technology Seminar Series was launched to help the general public better understand and explore how science transforms our world. \nDuring this inaugural COVID-19 seminar series talk\, Dr. Steven Wiley will discuss the differences in symptoms between a cold\, the flu\, and COVID-19\, in addition to the larger scientific story of COVID-19. What are the dangers\, really? What lessons have we learned over the last few months and how does COVID compare to past viral pandemics? What’s left for us to uncover? \nABOUT THE SPEAKER \nDr. Wiley is a systems biologist in the Functional and Systems Biology group in the Environmental Molecular Sciences Division and the Environmental Molecular Sciences Laboratory (EMSL) user program. He combines molecular and cellular biology with both biochemical and optical assays to generate quantitative data to build computational models of cellular processes. Wiley is the author or co-author of more than 200 scientific publications\, including more than 130 articles in peer-reviewed scientific journals\, and 30 review articles and book chapters. He also has written several commercial graphics and data analysis software packages. Dr. Wiley has served as a reviewer for more than 30 scientific journals\, is an associate editor of Frontiers in Genetics and is on the editorial board of The Scientist and BMC Biology. \nPlease visit the PNNL website for more information.
URL:https://globalbiodefense.com/event/demystifying-covid-seminar-series-hindsight-is-2020/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://pnnl.zoomgov.com/webinar/register/WN_t1dKS6PtSz21y58_5qngrg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T100000
DTEND;TZID=America/New_York:20210304T133000
DTSTAMP:20210225T172409Z
CREATED:20210225T172409Z
LAST-MODIFIED:20210225T172409Z
UID:48646-1614852000-1614864600@globalbiodefense.com
SUMMARY:Vulnerabilities in U.S. Chemical Weapons Detection\, Identification\, and Tracing
DESCRIPTION:The National Academies will host an expert discussion on Identifying and Accounting for Vulnerabilities in U.S. Chemical Weapons Detection\, Identification\, and Tracing Capabilities on March 4\, 2021. \nThe meeting is open to the public in virtual format and is part of a larger 2-day meeting of the Board on Chemical Sciences and Technology. \nThe Chemical Weapons session will explore the current state of the science in the field of chemical weapons detection\, identification\, and tracing\, and will highlight opportunities for additional research in this space. \nChemical weapons remain an ever-present\, high level threat to domestic and global security despite international efforts to regulate the weaponization of chemical agents. The recent use of deadly chemical agents in alleged assassination attempts of civilian targets has elevated interest in and attention to these weapons. This heightened awareness underscores critical knowledge gaps in the development of chemical weapons detection and identification technologies. The targeted deployment of chemical agents also demonstrates the advantages of employing forensic chemistry to investigate and trace chemical weapons. \nLeaders of panel discussions and Q&A sessions include: \n\nDr. Audrey M. Williams\, Director\, Forensic Science Center\, Lawrence Livermore National Laboratory (LLNL)\nDr. Carlos G. Fraga\, Senior Research Scientist\, Chemical and Biological Signatures Group\, Pacific Northwest National Laboratory (PNNL)\nDr. John Fortner\, Associate Professor of Chemical and Environmental Engineering at the Yale School of Engineering and Applied Science\nJennifer Sinclair Curtis\, University of California\, Davis\nScott Collick\, DuPont\n\nThis event will be webcast from the NASEM webpage. Registration is free and available here.
URL:https://globalbiodefense.com/event/vulnerabilities-in-u-s-chemical-weapons-detection-identification-and-tracing/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://www.nationalacademies.org/event/03-03-2021/board-on-chemical-sciences-and-technology-march-2021-meeting
END:VEVENT
END:VCALENDAR